These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 18647644)

  • 1. Measurement and correlation of solute solubility in HFA-134a/ethanol systems.
    Hoye JA; Myrdal PB
    Int J Pharm; 2008 Oct; 362(1-2):184-8. PubMed ID: 18647644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubility of solid solutes in HFA-134a with a correlation to physico-chemical properties.
    Hoye JA; Gupta A; Myrdal PB
    J Pharm Sci; 2008 Jan; 97(1):198-208. PubMed ID: 17828733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers.
    Gupta A; Stein SW; Myrdal PB
    J Aerosol Med; 2003; 16(2):167-74. PubMed ID: 12823910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of ethanol on the formation and physico-chemical properties of particles generated from budesonide solution-based pressurized metered-dose inhalers.
    Zhu B; Traini D; Chan HK; Young PM
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1625-37. PubMed ID: 24087854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers.
    Smyth HD; Hickey AJ
    AAPS PharmSciTech; 2003; 4(3):E38. PubMed ID: 14621970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation of the solubility of various compounds in the hydrofluoroalkane propellants and possible model liquid propellants.
    Dickinson PA; Seville PC; McHale H; Perkins NC; Taylor G
    J Aerosol Med; 2000; 13(3):179-86. PubMed ID: 11066021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized dose delivery of the peptide cyclosporine using hydrofluoroalkane-based metered dose inhalers.
    Myrdal PB; Karlage KL; Stein SW; Brown BA; Haynes A
    J Pharm Sci; 2004 Apr; 93(4):1054-61. PubMed ID: 14999741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of metered dose inhaler (MDI) formulations of ciclosporin.
    Marijani R; Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2007 Jan; 59(1):15-21. PubMed ID: 17227616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers.
    Buttini F; Miozzi M; Balducci AG; Royall PG; Brambilla G; Colombo P; Bettini R; Forbes B
    Int J Pharm; 2014 Apr; 465(1-2):42-51. PubMed ID: 24491530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation of a protein with propellant HFA 134a for aerosol delivery.
    Williams RO; Liu J
    Eur J Pharm Sci; 1999 Jan; 7(2):137-44. PubMed ID: 9845798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of two methods to determine the solubility of compounds in aerosol propellants.
    Gupta A; Myrdal PB
    Int J Pharm; 2005 Mar; 292(1-2):201-9. PubMed ID: 15725567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel method for the determination of solubility in aerosol propellants.
    Gupta A; Myrdal PB
    J Pharm Sci; 2004 Oct; 93(10):2411-9. PubMed ID: 15349951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-cancer effect of celecoxib and aerosolized docetaxel against human non-small cell lung cancer cell line, A549.
    Fulzele SV; Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2006 Mar; 58(3):327-36. PubMed ID: 16536899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers.
    Liao YH; Brown MB; Jones SA; Nazir T; Martin GP
    Int J Pharm; 2005 Nov; 304(1-2):29-39. PubMed ID: 16181753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel bottom-up process to produce nanoparticles containing protein and peptide for suspension in hydrofluoroalkane propellants.
    Tan Y; Yang Z; Peng X; Xin F; Xu Y; Feng M; Zhao C; Hu H; Wu C
    Int J Pharm; 2011 Jul; 413(1-2):167-73. PubMed ID: 21527322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.
    Ramsdell JW; Colice GL; Ekholm BP; Klinger NM
    Ann Allergy Asthma Immunol; 1998 Dec; 81(6):593-9. PubMed ID: 9892032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology.
    Kleinstreuer C; Shi H; Zhang Z
    J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient drug supersaturation kinetics of beclomethasone dipropionate in rapidly drying films.
    Reid ML; Jones SA; Brown MB
    Int J Pharm; 2009 Apr; 371(1-2):114-9. PubMed ID: 19150492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubility of organic solutes in ethanol/water mixtures.
    Li A; Yalkowsky SH
    J Pharm Sci; 1994 Dec; 83(12):1735-40. PubMed ID: 7891303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant solubility and aggregate orientation in hydrofluoroalkanes.
    Ridder KB; Davies-Cutting CJ; Kellaway IW
    Int J Pharm; 2005 May; 295(1-2):57-65. PubMed ID: 15847991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.